CVE:EMH Emerald Health Therapeutics (EMH) Stock Forecast, Price & News C$0.26 -0.01 (-3.77%) (As of 04/26/2021) Add Compare Share Share Today's RangeC$0.25▼C$0.2750-Day RangeC$0.26▼C$0.2652-Week RangeC$0.15▼C$0.53Volume384,329 shsAverage Volume644,760 shsMarket CapitalizationC$52.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsInsider TradesHeadlinesProfileChartCompetitorsEarningsInsider TradesHeadlines About Emerald Health Therapeutics (CVE:EMH) StockEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More Receive EMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address EMH Stock News HeadlinesMay 4, 2023 | health.usnews.comEmerald Care Center TulsaApril 25, 2023 | health.usnews.comEmerald ReegJune 9, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.March 14, 2023 | msn.comEmerald Expositions GAAP EPS of $0.06, revenue of $93.6MMarch 13, 2023 | sfgate.comTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riverMarch 4, 2023 | venturebeat.comVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceJanuary 14, 2023 | finance.yahoo.comEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearJanuary 4, 2023 | finance.yahoo.comEmerald Health Therapeutics Inc (TBD.BE)June 9, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.July 12, 2022 | finance.yahoo.comEmerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJune 16, 2022 | finance.yahoo.comEmerald Health Therapeutics Provides Bi-Weekly MCTO Status UpdateMay 16, 2022 | stockhouse.comEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status UpdateMay 12, 2022 | nz.finance.yahoo.comSkye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsJanuary 5, 2022 | investing.comEmperor Oil Ltd (EMh)December 31, 2021 | ca.finance.yahoo.comStocks in play: Emerald Health Therapeutics IncDecember 31, 2021 | stockhouse.comEmerald Health Therapeutics Reports 2021 AGM ResultsNovember 29, 2021 | msn.comEmerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On PharmaceuticalsNovember 29, 2021 | finance.yahoo.comEmerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical DevelopmentAugust 6, 2021 | news.yahoo.comEmerald Health Therapeutics Executive Chairman Avtar Dhillon ResignsMay 25, 2021 | ca.finance.yahoo.comEmerald Health Therapeutics Signs Letter of Intent for Product Co-Development Agreement with Prima Botanical Wellness BrandMay 3, 2021 | ca.finance.yahoo.comEmerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate UpdateDecember 17, 2020 | reuters.comAvricore Health IncDecember 1, 2020 | stockhouse.comEmerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateNovember 2, 2020 | law360.comCanadian Greenhouse Co. Takes Over Pot Venture For $60MSeptember 1, 2020 | seekingalpha.comEmerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2020 Results - Earnings Call TranscriptAugust 25, 2020 | au.finance.yahoo.comEMERALD HEALTH THER. (TBD.BE)August 3, 2020 | stockhouse.comEmerald Health Therapeutics Announces Stock Option GrantSee More Headlines EMH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:EMH CUSIPN/A CIKN/A Webwww.emerald.care Phone+1-250-8189838FaxN/AEmployees161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio35.45 Current Ratio2.97 Quick Ratio2.61 Sales & Book Value Annual SalesC$13.02 million Price / Sales4.02 Cash FlowC$0.33 per share Price / Cash Flow0.78 Book ValueC$0.40 per share Price / Book0.64Miscellaneous Outstanding Shares205,028,000Free FloatN/AMarket CapC$52.28 million OptionableNot Optionable BetaN/A Key ExecutivesDr. Avtar S. Dhillon (Age 59)Exec. Chairman Comp: $485.05kMr. Riaz Bandali M.B.A. (Age 51)CEO & Pres Comp: $428.21kMs. Jenn Hepburn B.B.A.CFO & Company Sec.Mr. Orville BovenschenSr. VP of OperationsMr. Bernie HertelVP of Fin. and CommunicationsMs. Rebecca WongSr. VP of Quality & Regulatory AffairsMore ExecutivesKey CompetitorsMicrobix BiosystemsTSE:MBXMedicenna TherapeuticsTSE:MDNACovalon TechnologiesCVE:COVProMIS NeurosciencesTSE:PMNHelix BioPharmaTSE:HBPView All Competitors EMH Stock - Frequently Asked Questions How have EMH shares performed in 2023? Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26. View the best growth stocks for 2023 here. What other stocks do shareholders of Emerald Health Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF). What is Emerald Health Therapeutics' stock symbol? Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH." How do I buy shares of Emerald Health Therapeutics? Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Emerald Health Therapeutics' stock price today? One share of EMH stock can currently be purchased for approximately C$0.26. How much money does Emerald Health Therapeutics make? Emerald Health Therapeutics (CVE:EMH) has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year. How many employees does Emerald Health Therapeutics have? The company employs 161 workers across the globe. How can I contact Emerald Health Therapeutics? Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The official website for the company is www.emerald.care. The company can be reached via phone at +1-250-8189838. This page (CVE:EMH) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.